Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 159 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Improving treatment of multidrug-resistant tuberculosis: Results of the endTB randomised clinical trial
L Guglielmetti,U Khan, GE Velasquez, M Gouillou,N Lachenal,I Motta,F Varaine,C Mitnick, Group endTB Study
Improving treatment of multidrug-resistant tuberculosis: Results of the endTB randomised clinical trial (2024)
Cited0Views0Bibtex
0
0
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin
Praharshinie Rupasinghe, Azka Ashraf,Nadia Barreda, Shafiqua Parveen, Muhammad Zubair,Roger Calderon,Sunil Asif, Nilma Hirani, Layila Chingisova,Atang Bulane,Pham Thu Hang, Doan Thu Ha,Elisa Ardizzoni, Nazia Kursheed,Willem Bram De Rijk,Leen Rigouts,Lorenzo Guglielmetti, Carol Mitnick,Bouke C. de Jong
ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 5 (2024): e0170123-e0170123
Cited0Views0WOSBibtex
0
0
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes
J. R. Campbell, E. D. Chen,L. F. Anderson, M. Bonnet,S. K. Brode,J. P. Cegielski,L. Guglielmetti,R. Singla,G. J. Fox,A. Skrahina, D. Rodrigues,L. Kuksa,P. Viiklepp,D. Menzies
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseaseno. 4 (2023): 338-340
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 164

#Citation: 3579

H-Index: 26

G-Index: 58

Sociability: 7

Diversity: 2

Activity: 63

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn